Trial intelligence / Profile preview

Long-term brain effects of childhood versus adult psychotropic exposure

NL-OMON36448Recruiting

Sponsor
Radiologie Holding
Start
May 2011
Modality
Small Molecules
Countries
1
01

Overview

Open-label trial of methylphenidate and fluoxetine in attention deficit hyperactivity disorder (ADHD), major depressive disorder (MDD) and anxiety disorder (6 arms), sponsored by Radiologie Holding. Primary endpoints: phMRI cerebral perfusion response, Diffusion tensor imaging metrics and 1 more. Started May 2011; status: recruiting.

02

Drugs

methylphenidatefluoxetine
03

Conditions

attention deficit hyperactivity disorder (ADHD)major depressive disorder (MDD)anxiety disorder

Beyond the preview

Go deeper on NL-OMON36448.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON36448.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call